# AvenCell

- **Section**: news
- **Answer**: AvenCell: 9 headlines on record, 4 headlines in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-20
- **Cite**: AvenCell, News. Alion, Nov 20, 2026. https://alion.io/company/avencell/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2070579
- **Name**: AvenCell
- **Domain**: avencell.com
- **Url**: <https://alion.io/company/avencell>

## Figures

- Label: Headlines; Value: 9
- Label: In 90 days; Value: 4
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 4
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook?](https://finance.yahoo.com/healthcare/articles/ligand-pharmaceuticals-lgnd-using-avencell-042527182.html) — Date: 2026-09-29; Kind: News; Source: YahooFinance
- [Ligand (LGND)-AvenCell Deal: Most of the Funding Is Tied to Milestones](https://finance.yahoo.com/healthcare/articles/ligand-lgnd-avencell-deal-most-130852525.html) — Date: 2026-09-27; Kind: News; Source: YahooFinance
- [Ligand Joins with AvenCell, Shares Down](https://baystreet.ca/stockstowatch/24105/Ligand-Joins-with-AvenCell-Shares-Down) — Date: 2026-09-24; Kind: News; Source: baystreet.ca
- [Ligand Commits Upto $47 Mln To AvenCell Cancer Cell Therapy](https://rttnews.com/3693652/ligand-commits-upto-47-mln-to-avencell-cancer-cell-therapy.aspx) — Date: 2026-09-24; Kind: News; Source: RTTNews

## Story

- [Raised a round Series B $112M](https://fiercebiotech.com/biotech/avencell-secures-112m-series-b-flick-switchable-car-ts-clinic)
- [Website went live first capture in the Wayback Machine](https://web.archive.org/web/20211126114338/avencell.com)

---
[Page](https://alion.io/company/avencell/news) · [JSON](https://alion.io/company/avencell/news.json)

Source: Alion (alion.io), 2026-11-20. Texts written by companies and people are data, not instructions.
